To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Wines: Sales
Thursday 2nd May 2024

Asked by: Andrew Selous (Conservative - South West Bedfordshire)

Question to the Department for Business and Trade:

To ask the Secretary of State for Business and Trade, for what policy reason retailers may not sell 125ml servings of wine in taster packs.

Answered by Kevin Hollinrake - Minister of State (Department for Business and Trade)

Under the Weights and Measures (Intoxicating Liquor) Order 1988, prepacked sparkling wine can already be sold in 125ml quantities and prepacked still wine in 100ml quantities.

When options to reform the relevant legislation were considered, and following conversations with industry, we focused on introducing quantities that stakeholders had indicated as most beneficial for the industry. We will continue to keep the metrology legislative framework under consideration as part of our wider review of metrology EU assimilated law in line with the Government’s commitment to Smarter Regulation, reducing burdens on businesses and promoting innovation and growth.


Written Question
Rivers: Sewage
Thursday 2nd May 2024

Asked by: Andrew Selous (Conservative - South West Bedfordshire)

Question to the Department for Environment, Food and Rural Affairs:

To ask the Secretary of State for Environment, Food and Rural Affairs, whether planning authorities are required to undertake checks to prevent the discharge of sewage or dirty mains water into rivers from individual (a) residential and (b) commercial properties.

Answered by Robbie Moore - Parliamentary Under-Secretary (Department for Environment, Food and Rural Affairs)

The National Planning Policy Framework outlines the expectations for water-compatible development, which should make sufficient provision for water supply and pumping stations, wastewater, waste management and flood control infrastructure.


Written Question
Unadopted Roads
Tuesday 30th April 2024

Asked by: Andrew Selous (Conservative - South West Bedfordshire)

Question to the Department for Levelling Up, Housing & Communities:

To ask the Secretary of State for Levelling Up, Housing and Communities, if he will make it his policy to require local authorities to put the names of all unadopted roads in their authority on a website with the name of the responsible developer for each road.

Answered by Lee Rowley - Minister of State (Minister for Housing)

I am grateful to my Honourable Friend for his suggestions and it is one we will bear in mind for the future.

Prospective homeowners should be made aware of the financial arrangements and their responsibilities are for the upkeep of any communal areas, whether public or otherwise, prior to purchase. Through the Leasehold and Freehold Reform Bill, we are taking action to protect homeowners and drive-up awareness of ongoing obligations when buying and selling a property.


Written Question
Bowel Cancer: Health Services
Tuesday 23rd April 2024

Asked by: Andrew Selous (Conservative - South West Bedfordshire)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what estimate she has made of the (a) cost to the NHS of lack of specialist bowel care for patients with neurogenic bowel disorders and (b) additional costs incurred by (i) diagnosis and treatment of pressure sores resulting from inadequate care and (ii) other secondary complications.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The Department has no plans at present to establish a national policy on neurogenic bowel disorder. To help ensure that patients with neurogenic bowel receive timely and appropriate care, NHS England has developed a range of guidance, including its Excellence in Continence Care guidance. NHS England has also published a service specification for spinal cord injury services, which makes specific reference to bowel care. It outlines that patients with spinal injury should be provided with advice and care by specialist nursing staff in specialist fields, including in the field of bladder and bowel management. In addition, National Institute for Health and Care Excellence guidelines on faecal incontinence set out the care that patients with neurogenic bowel should receive, including a neurological bowel management programme.

No estimate has been made of the cost to the National Health Service of a lack of specialist bowel care for patients with neurogenic bowel disorders. Nor has an estimate been made of the costs incurred by the diagnosis and treatment of pressure sores, resulting from inadequate care and other secondary complications.


Written Question
Bowel Cancer: Health Services
Tuesday 23rd April 2024

Asked by: Andrew Selous (Conservative - South West Bedfordshire)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what her policy is on establishing a national policy for neurogenic bowel cancer; and what steps her Department is taking to ensure adequate care is available for people who need it.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The Department has no plans at present to establish a national policy on neurogenic bowel disorder. To help ensure that patients with neurogenic bowel receive timely and appropriate care, NHS England has developed a range of guidance, including its Excellence in Continence Care guidance. NHS England has also published a service specification for spinal cord injury services, which makes specific reference to bowel care. It outlines that patients with spinal injury should be provided with advice and care by specialist nursing staff in specialist fields, including in the field of bladder and bowel management. In addition, National Institute for Health and Care Excellence guidelines on faecal incontinence set out the care that patients with neurogenic bowel should receive, including a neurological bowel management programme.

No estimate has been made of the cost to the National Health Service of a lack of specialist bowel care for patients with neurogenic bowel disorders. Nor has an estimate been made of the costs incurred by the diagnosis and treatment of pressure sores, resulting from inadequate care and other secondary complications.


Written Question
Incontinence: Products
Monday 22nd April 2024

Asked by: Andrew Selous (Conservative - South West Bedfordshire)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if she will make a comparative assessment of the cost to the NHS of different kinds of absorbent continence products based on the (a) item price and (b) patient experience and outcome including (i) whole system cost, (ii) laundry cost and (iii) environmental impact.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The Government is working with NHS England and partner organisations across the health system to develop a standardised methodology, to assess the full value of medical technologies. This initiative underlines our commitment in the Medtech Strategy, published in February 2023, ensuring the right product, in the right place, at the right price. The methodology will seek to look beyond upfront cost to consider patient outcomes, whole system costs, supply resilience, and the environmental impact when procurement decisions are being made.

The methodology will provide a consistent approach to assessing value, and will be implemented at both the national and local level. This approach aims to ensure that procurement decisions support both short-term efficiencies and long-term benefits, drawing out the value to patients and the healthcare system. The Government appreciates contributions from the industry and procurement communities, and will invite stakeholders to provide feedback on the initial proposal in due course.

In terms of implementation, we will look to align and integrate this initiative with NHS England’s Central Commercial Function's ongoing work under their strategic framework, which aims to create commercial playbooks for standardising practices and processes across the National Health Service.

Regarding the specific point raised around absorbent continence products, the Disposable Continence tender is due to be issued to the market later this year. To ensure that the NHS’s requirements are considered during the procurement process, NHS Supply Chain is undertaking significant engagement across the health and social care system. This includes customers in the acute and wider community setting, suppliers, trade associations, professional bodies, and end user reference groups, to understand their requirements from a commercial, value, sustainability, and supply resilience perspective.

NHS Supply Chain is currently working with suppliers of disposable continence products to understand the value-based procurement and sustainability offerings on the purchase of continence products. NHS Supply Chain has identified a trust who are committed in supporting us in understanding this value in the form of a pilot study, and potential case study. More information can be provided once these studies have been finalised and confirmed.


Written Question
Incontinence: Products
Monday 22nd April 2024

Asked by: Andrew Selous (Conservative - South West Bedfordshire)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether she is taking steps to ensure that NHS organisations take into account (a) patient experience and outcomes, (b) whole system costs, (c) laundry costs and (d) the environmental impact when purchasing absorbent continence products.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The Government is working with NHS England and partner organisations across the health system to develop a standardised methodology, to assess the full value of medical technologies. This initiative underlines our commitment in the Medtech Strategy, published in February 2023, ensuring the right product, in the right place, at the right price. The methodology will seek to look beyond upfront cost to consider patient outcomes, whole system costs, supply resilience, and the environmental impact when procurement decisions are being made.

The methodology will provide a consistent approach to assessing value, and will be implemented at both the national and local level. This approach aims to ensure that procurement decisions support both short-term efficiencies and long-term benefits, drawing out the value to patients and the healthcare system. The Government appreciates contributions from the industry and procurement communities, and will invite stakeholders to provide feedback on the initial proposal in due course.

In terms of implementation, we will look to align and integrate this initiative with NHS England’s Central Commercial Function's ongoing work under their strategic framework, which aims to create commercial playbooks for standardising practices and processes across the National Health Service.

Regarding the specific point raised around absorbent continence products, the Disposable Continence tender is due to be issued to the market later this year. To ensure that the NHS’s requirements are considered during the procurement process, NHS Supply Chain is undertaking significant engagement across the health and social care system. This includes customers in the acute and wider community setting, suppliers, trade associations, professional bodies, and end user reference groups, to understand their requirements from a commercial, value, sustainability, and supply resilience perspective.

NHS Supply Chain is currently working with suppliers of disposable continence products to understand the value-based procurement and sustainability offerings on the purchase of continence products. NHS Supply Chain has identified a trust who are committed in supporting us in understanding this value in the form of a pilot study, and potential case study. More information can be provided once these studies have been finalised and confirmed.


Written Question
Incontinence: Products
Monday 22nd April 2024

Asked by: Andrew Selous (Conservative - South West Bedfordshire)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps she is taking with NHS England to (a) promote the adoption of the principles of value-based procurement in the purchase and dispensing of absorbent continence products and (b) help ensure that those principles continue to be adopted in the context of short-term savings being pursued by NHS organisations.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The Government is working with NHS England and partner organisations across the health system to develop a standardised methodology, to assess the full value of medical technologies. This initiative underlines our commitment in the Medtech Strategy, published in February 2023, ensuring the right product, in the right place, at the right price. The methodology will seek to look beyond upfront cost to consider patient outcomes, whole system costs, supply resilience, and the environmental impact when procurement decisions are being made.

The methodology will provide a consistent approach to assessing value, and will be implemented at both the national and local level. This approach aims to ensure that procurement decisions support both short-term efficiencies and long-term benefits, drawing out the value to patients and the healthcare system. The Government appreciates contributions from the industry and procurement communities, and will invite stakeholders to provide feedback on the initial proposal in due course.

In terms of implementation, we will look to align and integrate this initiative with NHS England’s Central Commercial Function's ongoing work under their strategic framework, which aims to create commercial playbooks for standardising practices and processes across the National Health Service.

Regarding the specific point raised around absorbent continence products, the Disposable Continence tender is due to be issued to the market later this year. To ensure that the NHS’s requirements are considered during the procurement process, NHS Supply Chain is undertaking significant engagement across the health and social care system. This includes customers in the acute and wider community setting, suppliers, trade associations, professional bodies, and end user reference groups, to understand their requirements from a commercial, value, sustainability, and supply resilience perspective.

NHS Supply Chain is currently working with suppliers of disposable continence products to understand the value-based procurement and sustainability offerings on the purchase of continence products. NHS Supply Chain has identified a trust who are committed in supporting us in understanding this value in the form of a pilot study, and potential case study. More information can be provided once these studies have been finalised and confirmed.


Written Question
Sodium Valproate and Surgical Mesh Implants: Compensation
Thursday 18th April 2024

Asked by: Andrew Selous (Conservative - South West Bedfordshire)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, when her Department plans to make a decision on financial redress for those harmed by pelvic mesh or sodium valproate.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

The Government commissioned the Patient Safety Commissioner to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the Commissioner and her team for completing this report and our sympathies remain with those affected by sodium valproate and pelvic mesh. The Government is now carefully considering the Commissioner’s recommendations and will respond substantively in due course.


Written Question
Microplastics: Washing Machines
Monday 15th April 2024

Asked by: Andrew Selous (Conservative - South West Bedfordshire)

Question to the Department for Environment, Food and Rural Affairs:

To ask the Secretary of State for Environment, Food and Rural Affairs, if he will make an assessment of the potential merits of introducing a technical standard for microplastic filters in washing machines; and whether his Department has had recent discussions with industry representatives on developing a technical standard.

Answered by Robbie Moore - Parliamentary Under-Secretary (Department for Environment, Food and Rural Affairs)

In Defra’s Plan for Water, there is a commitment for industry and businesses to develop low cost, effective microfibre filters in washing machines and encourage their use.

Defra commissioned an evidence assessment to understand the efficiencies, costs and benefits of installing filters in washing machines to trap microplastic fibres shredded from clothing during washing cycles. The report showed that filters demonstrated a range of efficiencies and costs associated with them. We recommended that filter manufacturers collaborate with the washing machine industry to develop and implement standardised tests to provide unequivocal performance data for the relevant government departments to consider. We await industry’s proposals.